We are live on ! Find out more
WCM

Wildcat Capital Management Portfolio holdings

AUM $229M
1-Year Est. Return 132.65%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$131M
AUM Growth
+$9.5M
Cap. Flow
-$678K
Cap. Flow %
-0.52%
Top 10 Hldgs %
97.42%
Holding
17
New
3
Increased
3
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
URGN icon
UroGen Pharma
URGN
+$4.06M
2
COUP
Coupa Software Incorporated
COUP
+$285K
3
SBR
Sabine Royalty Trust
SBR
+$8.03K

Top Sells

Rank Stock Value
1
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
+$3.09M
2
CSGP icon
CoStar Group
CSGP
+$1.94M

Sector Composition

Rank Sector Weight
1 Real Estate 46.71%
2 Healthcare 21.69%
3 Financials 10.41%
4 Energy 10.38%
5 Communication Services 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSGP icon
1
CoStar Group
CSGP
$12.8B
$61.1M 46.71%
1,479,770
-50,300
-3% -$1.94M
LPLA icon
2
LPL Financial
LPLA
$26.9B
$13.6M 10.41%
208,401
– –
SBR
3
Sabine Royalty Trust
SBR
$1.09B
$13.6M 10.38%
289,963
+173
+0.1% +$8.03K
URGN icon
4
UroGen Pharma
URGN
$2.04B
$12.5M 9.57%
251,459
+69,757
+38% +$4.06M
EDIT icon
5
Editas Medicine
EDIT
$404M
$6.65M 5.09%
185,668
– –
PLAY icon
6
Dave & Buster's
PLAY
$239M
$5.71M 4.37%
120,000
– –
SNNA
7
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$4.49M 3.43%
295,613
– –
APPF icon
8
AppFolio
APPF
$8B
$3.51M 2.68%
57,372
– –
PLYA
9
DELISTED
Playa Hotels & Resorts
PLYA
$3.24M 2.48%
300,000
– –
SRNE
10
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$2.99M 2.29%
415,765
– –
IBRX icon
11
ImmunityBio
IBRX
$8.63B
$1.7M 1.3%
556,453
– –
COUP
12
DELISTED
Coupa Software Incorporated
COUP
$999K 0.76%
16,056
+5,352
+50% +$285K
NH
13
DELISTED
NantHealth, Inc
NH
$663K 0.51%
13,358
– –
RDOG icon
14
PUT
ALPS REIT Dividend Dogs ETF
RDOG
$10.9M
$2K ﹤0.01%
+465,000
New +$20.1M
OEF icon
15
CALL
iShares S&P 100 ETF
OEF
$20.1B
$1K ﹤0.01%
+115,200
New +$13.7M
VXX
16
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$1K ﹤0.01%
+55,200
New +$2.13M
VXX
17
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-80,000
Closed -$3.09M

Similar funds

IAAG
Innovative Asset Advisors Group Shelton, Connecticut $229M AUM
DCC
Dow Chemical Company Midland, Michigan $228M AUM 0.84% 1-Year Est. Return
TI
tru Independence Portland, Oregon $229M AUM 22.02% 1-Year Est. Return
SPFA
Summit Place Financial Advisors Summit, New Jersey $228M AUM 26.15% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
PPA
Painted Porch Advisors Santa Barbara, California $229M AUM 17.97% 1-Year Est. Return
SWIM
Smallwood Wealth Investment Management Red Bank, New Jersey $229M AUM 23.56% 1-Year Est. Return
PRRFG
Paul R. Ried Financial Group Bellevue, Washington $229M AUM 29.24% 1-Year Est. Return

Wildcat Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Wildcat Capital Management held 17 positions worth $131M, up 7.8% from $121M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Wildcat Capital Management's Q2 2018 filing shows 3 new, 3 increased, 1 reduced and 1 closed positions. The largest sale was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $3.09M.

By sector, the portfolio is most concentrated in Real Estate at 47% of assets, up from 46% a quarter earlier, followed by Healthcare and Financials.

  • Wildcat Capital Management added most to UroGen Pharma in Q2 2018, an estimated $4.06M increase.
  • Wildcat Capital Management's biggest Q2 2018 reduction was CoStar Group, cutting an estimated $1.94M.
  • Wildcat Capital Management fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q2 2018, selling an estimated $3.09M.
  • Wildcat Capital Management's ten largest holdings make up 97% of its $131M portfolio in Q2 2018.
  • Wildcat Capital Management opened 3 new positions and closed 1 in Q2 2018.
  • Wildcat Capital Management's portfolio value rose 7.8% quarter-over-quarter to $131M.

Based on Wildcat Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.